APO Research
Talk to an analyst

APO RESEARCH · REPORT

Omega3 (Omega-3)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Omega3 (Omega-3) Market Outlook and Growth Opportunities 2026

21 December 2025211 pages

Choose your research edition.

Industry ResearchOmega3 (Omega-3) Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Omega3 (Omega-3) Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Omega3 (Omega-3) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Omega3 (Omega-3) Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Omega3 (Omega-3) Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Omega3 (Omega-3) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Omega3 (Omega-3) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Omega3 (Omega-3) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Omega3 (Omega-3) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Omega3 (Omega-3) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Omega3 (Omega-3) market include DSM, Skuny, Shandong Yuwang Pharmaceutical, BASF, Xinzhou, TASA, Solutex, Sinomega and Polaris, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Omega3 (Omega-3) market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Omega3 (Omega-3) and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Omega3 (Omega-3) revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Omega3 (Omega-3) market.

Omega3 (Omega-3) Segment by Company

DSM

Skuny

Shandong Yuwang Pharmaceutical

BASF

Xinzhou

TASA

Solutex

Sinomega

Polaris

Orkla Health

Omega Protein

OLVEA Fish Oils

Nippon Suisan Kaisha

Maruha Nichiro Foods

LYSI

Kinomega

KD Pharma(Marine Ingredients)

KD Pharma

Hofseth BioCare

Golden Omega

GC Rieber

EPAX

Croda

Bioprocess Algae

Auqi

Anti-Cancer

Omega3 (Omega-3) Segment by Type

Marine Source

Algae Source

Omega3 (Omega-3) Segment by Application

Pharmaceuticals

Infant Formula

Dietary Supplements

Fortified Food and Beverage

Pet Foods

Others

Omega3 (Omega-3) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Omega3 (Omega-3) status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Omega3 (Omega-3) key companies, revenue, market share, and recent developments.

3. To split the Omega3 (Omega-3) breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Omega3 (Omega-3) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Omega3 (Omega-3) significant trends, drivers, influence factors in global and regions.

6. To analyze Omega3 (Omega-3) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Omega3 (Omega-3) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Omega3 (Omega-3) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Omega3 (Omega-3).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Omega3 (Omega-3) industry.

Chapter 3: Detailed analysis of Omega3 (Omega-3) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Omega3 (Omega-3) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Omega3 (Omega-3) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Omega3 (Omega-3) Industry Trends Table 2. Omega3 (Omega-3) Industry Drivers Table 3. Omega3 (Omega-3) Industry Opportunities and Challenges Table 4. Omega3 (Omega-3) Industry Restraints Table 5. Global Omega3 (Omega-3) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Omega3 (Omega-3) Revenue Share by Company (2021-2026) Table 7. Global Omega3 (Omega-3) Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Omega3 (Omega-3) Key Company Manufacturing Base & Headquarters Table 9. Global Omega3 (Omega-3) Company, Product Type & Application Table 10. Global Omega3 (Omega-3) Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Omega3 (Omega-3) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Marine Source Table 15. Significant Companies of Algae Source Table 16. Global Omega3 (Omega-3) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Omega3 (Omega-3) Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Omega3 (Omega-3) Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Omega3 (Omega-3) Sales Value Share by Type (2021-2026) Table 20. Global Omega3 (Omega-3) Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Pharmaceuticals Table 22. Significant Companies of Infant Formula Table 23. Significant Companies of Dietary Supplements Table 24. Significant Companies of Fortified Food and Beverage Table 25. Significant Companies of Pet Foods Table 26. Significant Companies of Others Table 27. Global Omega3 (Omega-3) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Omega3 (Omega-3) Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Omega3 (Omega-3) Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Omega3 (Omega-3) Sales Value Share by Application (2021-2026) Table 31. Global Omega3 (Omega-3) Sales Value Share by Application (2027-2032) Table 32. Global Omega3 (Omega-3) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Omega3 (Omega-3) Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Omega3 (Omega-3) Sales Value Share by Region (2021-2026) Table 35. Global Omega3 (Omega-3) Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Omega3 (Omega-3) Sales Value Share by Region (2027-2032) Table 37. Global Omega3 (Omega-3) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Omega3 (Omega-3) Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Omega3 (Omega-3) Sales Value Market Share by Country (2021-2026) Table 40. Global Omega3 (Omega-3) Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Omega3 (Omega-3) Sales Value Market Share by Country (2027-2032) Table 42. DSM Company Information Table 43. DSM Business Overview Table 44. DSM Omega3 (Omega-3) Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. DSM Omega3 (Omega-3) Product Portfolio Table 46. DSM Recent Development Table 47. Skuny Company Information Table 48. Skuny Business Overview Table 49. Skuny Omega3 (Omega-3) Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Skuny Omega3 (Omega-3) Product Portfolio Table 51. Skuny Recent Development Table 52. Shandong Yuwang Pharmaceutical Company Information Table 53. Shandong Yuwang Pharmaceutical Business Overview Table 54. Shandong Yuwang Pharmaceutical Omega3 (Omega-3) Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Shandong Yuwang Pharmaceutical Omega3 (Omega-3) Product Portfolio Table 56. Shandong Yuwang Pharmaceutical Recent Development Table 57. BASF Company Information Table 58. BASF Business Overview Table 59. BASF Omega3 (Omega-3) Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. BASF Omega3 (Omega-3) Product Portfolio Table 61. BASF Recent Development Table 62. Xinzhou Company Information Table 63. Xinzhou Business Overview Table 64. Xinzhou Omega3 (Omega-3) Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Xinzhou Omega3 (Omega-3) Product Portfolio Table 66. Xinzhou Recent Development Table 67. TASA Company Information Table 68. TASA Business Overview Table 69. TASA Omega3 (Omega-3) Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. TASA Omega3 (Omega-3) Product Portfolio Table 71. TASA Recent Development Table 72. Solutex Company Information Table 73. Solutex Business Overview Table 74. Solutex Omega3 (Omega-3) Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Solutex Omega3 (Omega-3) Product Portfolio Table 76. Solutex Recent Development Table 77. Sinomega Company Information Table 78. Sinomega Business Overview Table 79. Sinomega Omega3 (Omega-3) Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Sinomega Omega3 (Omega-3) Product Portfolio Table 81. Sinomega Recent Development Table 82. Polaris Company Information Table 83. Polaris Business Overview Table 84. Polaris Omega3 (Omega-3) Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Polaris Omega3 (Omega-3) Product Portfolio Table 86. Polaris Recent Development Table 87. Orkla Health Company Information Table 88. Orkla Health Business Overview Table 89. Orkla Health Omega3 (Omega-3) Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Orkla Health Omega3 (Omega-3) Product Portfolio Table 91. Orkla Health Recent Development Table 92. Omega Protein Company Information Table 93. Omega Protein Business Overview Table 94. Omega Protein Omega3 (Omega-3) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Omega Protein Omega3 (Omega-3) Product Portfolio Table 96. Omega Protein Recent Development Table 97. OLVEA Fish Oils Company Information Table 98. OLVEA Fish Oils Business Overview Table 99. OLVEA Fish Oils Omega3 (Omega-3) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. OLVEA Fish Oils Omega3 (Omega-3) Product Portfolio Table 101. OLVEA Fish Oils Recent Development Table 102. Nippon Suisan Kaisha Company Information Table 103. Nippon Suisan Kaisha Business Overview Table 104. Nippon Suisan Kaisha Omega3 (Omega-3) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Nippon Suisan Kaisha Omega3 (Omega-3) Product Portfolio Table 106. Nippon Suisan Kaisha Recent Development Table 107. Maruha Nichiro Foods Company Information Table 108. Maruha Nichiro Foods Business Overview Table 109. Maruha Nichiro Foods Omega3 (Omega-3) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Maruha Nichiro Foods Omega3 (Omega-3) Product Portfolio Table 111. Maruha Nichiro Foods Recent Development Table 112. LYSI Company Information Table 113. LYSI Business Overview Table 114. LYSI Omega3 (Omega-3) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. LYSI Omega3 (Omega-3) Product Portfolio Table 116. LYSI Recent Development Table 117. Kinomega Company Information Table 118. Kinomega Business Overview Table 119. Kinomega Omega3 (Omega-3) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. Kinomega Omega3 (Omega-3) Product Portfolio Table 121. Kinomega Recent Development Table 122. KD Pharma(Marine Ingredients) Company Information Table 123. KD Pharma(Marine Ingredients) Business Overview Table 124. KD Pharma(Marine Ingredients) Omega3 (Omega-3) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. KD Pharma(Marine Ingredients) Omega3 (Omega-3) Product Portfolio Table 126. KD Pharma(Marine Ingredients) Recent Development Table 127. KD Pharma Company Information Table 128. KD Pharma Business Overview Table 129. KD Pharma Omega3 (Omega-3) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 130. KD Pharma Omega3 (Omega-3) Product Portfolio Table 131. KD Pharma Recent Development Table 132. Hofseth BioCare Company Information Table 133. Hofseth BioCare Business Overview Table 134. Hofseth BioCare Omega3 (Omega-3) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 135. Hofseth BioCare Omega3 (Omega-3) Product Portfolio Table 136. Hofseth BioCare Recent Development Table 137. Golden Omega Company Information Table 138. Golden Omega Business Overview Table 139. Golden Omega Omega3 (Omega-3) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 140. Golden Omega Omega3 (Omega-3) Product Portfolio Table 141. Golden Omega Recent Development Table 142. GC Rieber Company Information Table 143. GC Rieber Business Overview Table 144. GC Rieber Omega3 (Omega-3) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 145. GC Rieber Omega3 (Omega-3) Product Portfolio Table 146. GC Rieber Recent Development Table 147. EPAX Company Information Table 148. EPAX Business Overview Table 149. EPAX Omega3 (Omega-3) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 150. EPAX Omega3 (Omega-3) Product Portfolio Table 151. EPAX Recent Development Table 152. Croda Company Information Table 153. Croda Business Overview Table 154. Croda Omega3 (Omega-3) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 155. Croda Omega3 (Omega-3) Product Portfolio Table 156. Croda Recent Development Table 157. Bioprocess Algae Company Information Table 158. Bioprocess Algae Business Overview Table 159. Bioprocess Algae Omega3 (Omega-3) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 160. Bioprocess Algae Omega3 (Omega-3) Product Portfolio Table 161. Bioprocess Algae Recent Development Table 162. Auqi Company Information Table 163. Auqi Business Overview Table 164. Auqi Omega3 (Omega-3) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 165. Auqi Omega3 (Omega-3) Product Portfolio Table 166. Auqi Recent Development Table 167. Anti-Cancer Company Information Table 168. Anti-Cancer Business Overview Table 169. Anti-Cancer Omega3 (Omega-3) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 170. Anti-Cancer Omega3 (Omega-3) Product Portfolio Table 171. Anti-Cancer Recent Development Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Omega3 (Omega-3) Product Image Figure 2. Global Omega3 (Omega-3) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Omega3 (Omega-3) Market Size (2021-2032) & (US$ Million) Figure 4. Global Omega3 (Omega-3) Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Marine Source Image Figure 8. Algae Source Image Figure 9. Global Omega3 (Omega-3) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Omega3 (Omega-3) Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Omega3 (Omega-3) Sales Value Share by Type (2021-2032) Figure 12. Pharmaceuticals Image Figure 13. Infant Formula Image Figure 14. Dietary Supplements Image Figure 15. Fortified Food and Beverage Image Figure 16. Pet Foods Image Figure 17. Others Image Figure 18. Global Omega3 (Omega-3) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Omega3 (Omega-3) Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Omega3 (Omega-3) Sales Value Share by Application (2021-2032) Figure 21. Global Omega3 (Omega-3) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Omega3 (Omega-3) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Omega3 (Omega-3) Sales Value (2021-2032) & (US$ Million) Figure 24. North America Omega3 (Omega-3) Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Omega3 (Omega-3) Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Omega3 (Omega-3) Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Omega3 (Omega-3) Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Omega3 (Omega-3) Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Omega3 (Omega-3) Sales Value (2021-2032) & (US$ Million) Figure 30. South America Omega3 (Omega-3) Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Omega3 (Omega-3) Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Omega3 (Omega-3) Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Omega3 (Omega-3) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Marine Source
  • Algae Source
Applications
  • Pharmaceuticals
  • Infant Formula
  • Dietary Supplements
  • Fortified Food and Beverage
  • Pet Foods
  • Others
Companies covered
  • DSM
  • Skuny
  • Shandong Yuwang Pharmaceutical
  • BASF
  • Xinzhou
  • TASA
  • Solutex
  • Sinomega
  • Polaris
  • Orkla Health
  • Omega Protein
  • OLVEA Fish Oils
  • Nippon Suisan Kaisha
  • Maruha Nichiro Foods
  • LYSI
  • Kinomega
  • KD Pharma(Marine Ingredients)
  • KD Pharma
  • Hofseth BioCare
  • Golden Omega
  • GC Rieber
  • EPAX
  • Croda
  • Bioprocess Algae
  • Auqi
  • Anti-Cancer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Omega3 (Omega-3) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Omega3 (Omega-3) Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Omega3 (Omega-3) Market Dynamics
  1. 2.1 Omega3 (Omega-3) Industry Trends
  2. 2.2 Omega3 (Omega-3) Industry Drivers
  3. 2.3 Omega3 (Omega-3) Industry Opportunities and Challenges
  4. 2.4 Omega3 (Omega-3) Industry Restraints
3 Omega3 (Omega-3) Market by Company
  1. 3.1 Global Omega3 (Omega-3) Company Revenue Ranking in 2025
  2. 3.2 Global Omega3 (Omega-3) Revenue by Company (2021-2026)
  3. 3.3 Global Omega3 (Omega-3) Company Ranking (2024-2026)
  4. 3.4 Global Omega3 (Omega-3) Company Manufacturing Base and Headquarters
  5. 3.5 Global Omega3 (Omega-3) Company Product Type and Application
  6. 3.6 Global Omega3 (Omega-3) Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Omega3 (Omega-3) Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Omega3 (Omega-3) Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Omega3 (Omega-3) Market by Type
  1. 4.1 Omega3 (Omega-3) Type Introduction
  2. 4.1.1 Marine Source
  3. 4.1.2 Algae Source
  4. 4.2 Global Omega3 (Omega-3) Sales Value by Type
  5. 4.2.1 Global Omega3 (Omega-3) Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Omega3 (Omega-3) Sales Value by Type (2021-2032)
  7. 4.2.3 Global Omega3 (Omega-3) Sales Value Share by Type (2021-2032)
5 Omega3 (Omega-3) Market by Application
  1. 5.1 Omega3 (Omega-3) Application Introduction
  2. 5.1.1 Pharmaceuticals
  3. 5.1.2 Infant Formula
  4. 5.1.3 Dietary Supplements
  5. 5.1.4 Fortified Food and Beverage
  6. 5.1.5 Pet Foods
  7. 5.1.6 Others
  8. 5.2 Global Omega3 (Omega-3) Sales Value by Application
  9. 5.2.1 Global Omega3 (Omega-3) Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Omega3 (Omega-3) Sales Value by Application (2021-2032)
  11. 5.2.3 Global Omega3 (Omega-3) Sales Value Share by Application (2021-2032)
6 Omega3 (Omega-3) Regional Value Analysis
  1. 6.1 Global Omega3 (Omega-3) Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Omega3 (Omega-3) Sales Value by Region (2021-2032)
  3. 6.2.1 Global Omega3 (Omega-3) Sales Value by Region: 2021-2026
  4. 6.2.2 Global Omega3 (Omega-3) Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Omega3 (Omega-3) Sales Value (2021-2032)
  7. 6.3.2 North America Omega3 (Omega-3) Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Omega3 (Omega-3) Sales Value (2021-2032)
  10. 6.4.2 Europe Omega3 (Omega-3) Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Omega3 (Omega-3) Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Omega3 (Omega-3) Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Omega3 (Omega-3) Sales Value (2021-2032)
  16. 6.6.2 South America Omega3 (Omega-3) Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Omega3 (Omega-3) Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Omega3 (Omega-3) Sales Value Share by Country, 2025 VS 2032
7 Omega3 (Omega-3) Country-level Value Analysis
  1. 7.1 Global Omega3 (Omega-3) Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Omega3 (Omega-3) Sales Value by Country (2021-2032)
  3. 7.2.1 Global Omega3 (Omega-3) Sales Value by Country (2021-2026)
  4. 7.2.2 Global Omega3 (Omega-3) Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Omega3 (Omega-3) Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Omega3 (Omega-3) Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Omega3 (Omega-3) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 DSM
  2. 8.1.1 DSM Company Information
  3. 8.1.2 DSM Business Overview
  4. 8.1.3 DSM Omega3 (Omega-3) Revenue and Gross Margin (2021-2026)
  5. 8.1.4 DSM Omega3 (Omega-3) Product Portfolio
  6. 8.1.5 DSM Recent Developments
  7. 8.2 Skuny
  8. 8.2.1 Skuny Company Information
  9. 8.2.2 Skuny Business Overview
  10. 8.2.3 Skuny Omega3 (Omega-3) Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Skuny Omega3 (Omega-3) Product Portfolio
  12. 8.2.5 Skuny Recent Developments
  13. 8.3 Shandong Yuwang Pharmaceutical
  14. 8.3.1 Shandong Yuwang Pharmaceutical Company Information
  15. 8.3.2 Shandong Yuwang Pharmaceutical Business Overview
  16. 8.3.3 Shandong Yuwang Pharmaceutical Omega3 (Omega-3) Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shandong Yuwang Pharmaceutical Omega3 (Omega-3) Product Portfolio
  18. 8.3.5 Shandong Yuwang Pharmaceutical Recent Developments
  19. 8.4 BASF
  20. 8.4.1 BASF Company Information
  21. 8.4.2 BASF Business Overview
  22. 8.4.3 BASF Omega3 (Omega-3) Revenue and Gross Margin (2021-2026)
  23. 8.4.4 BASF Omega3 (Omega-3) Product Portfolio
  24. 8.4.5 BASF Recent Developments
  25. 8.5 Xinzhou
  26. 8.5.1 Xinzhou Company Information
  27. 8.5.2 Xinzhou Business Overview
  28. 8.5.3 Xinzhou Omega3 (Omega-3) Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Xinzhou Omega3 (Omega-3) Product Portfolio
  30. 8.5.5 Xinzhou Recent Developments
  31. 8.6 TASA
  32. 8.6.1 TASA Company Information
  33. 8.6.2 TASA Business Overview
  34. 8.6.3 TASA Omega3 (Omega-3) Revenue and Gross Margin (2021-2026)
  35. 8.6.4 TASA Omega3 (Omega-3) Product Portfolio
  36. 8.6.5 TASA Recent Developments
  37. 8.7 Solutex
  38. 8.7.1 Solutex Company Information
  39. 8.7.2 Solutex Business Overview
  40. 8.7.3 Solutex Omega3 (Omega-3) Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Solutex Omega3 (Omega-3) Product Portfolio
  42. 8.7.5 Solutex Recent Developments
  43. 8.8 Sinomega
  44. 8.8.1 Sinomega Company Information
  45. 8.8.2 Sinomega Business Overview
  46. 8.8.3 Sinomega Omega3 (Omega-3) Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Sinomega Omega3 (Omega-3) Product Portfolio
  48. 8.8.5 Sinomega Recent Developments
  49. 8.9 Polaris
  50. 8.9.1 Polaris Company Information
  51. 8.9.2 Polaris Business Overview
  52. 8.9.3 Polaris Omega3 (Omega-3) Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Polaris Omega3 (Omega-3) Product Portfolio
  54. 8.9.5 Polaris Recent Developments
  55. 8.10 Orkla Health
  56. 8.10.1 Orkla Health Company Information
  57. 8.10.2 Orkla Health Business Overview
  58. 8.10.3 Orkla Health Omega3 (Omega-3) Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Orkla Health Omega3 (Omega-3) Product Portfolio
  60. 8.10.5 Orkla Health Recent Developments
  61. 8.11 Omega Protein
  62. 8.11.1 Omega Protein Company Information
  63. 8.11.2 Omega Protein Business Overview
  64. 8.11.3 Omega Protein Omega3 (Omega-3) Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Omega Protein Omega3 (Omega-3) Product Portfolio
  66. 8.11.5 Omega Protein Recent Developments
  67. 8.12 OLVEA Fish Oils
  68. 8.12.1 OLVEA Fish Oils Company Information
  69. 8.12.2 OLVEA Fish Oils Business Overview
  70. 8.12.3 OLVEA Fish Oils Omega3 (Omega-3) Revenue and Gross Margin (2021-2026)
  71. 8.12.4 OLVEA Fish Oils Omega3 (Omega-3) Product Portfolio
  72. 8.12.5 OLVEA Fish Oils Recent Developments
  73. 8.13 Nippon Suisan Kaisha
  74. 8.13.1 Nippon Suisan Kaisha Company Information
  75. 8.13.2 Nippon Suisan Kaisha Business Overview
  76. 8.13.3 Nippon Suisan Kaisha Omega3 (Omega-3) Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Nippon Suisan Kaisha Omega3 (Omega-3) Product Portfolio
  78. 8.13.5 Nippon Suisan Kaisha Recent Developments
  79. 8.14 Maruha Nichiro Foods
  80. 8.14.1 Maruha Nichiro Foods Company Information
  81. 8.14.2 Maruha Nichiro Foods Business Overview
  82. 8.14.3 Maruha Nichiro Foods Omega3 (Omega-3) Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Maruha Nichiro Foods Omega3 (Omega-3) Product Portfolio
  84. 8.14.5 Maruha Nichiro Foods Recent Developments
  85. 8.15 LYSI
  86. 8.15.1 LYSI Company Information
  87. 8.15.2 LYSI Business Overview
  88. 8.15.3 LYSI Omega3 (Omega-3) Revenue and Gross Margin (2021-2026)
  89. 8.15.4 LYSI Omega3 (Omega-3) Product Portfolio
  90. 8.15.5 LYSI Recent Developments
  91. 8.16 Kinomega
  92. 8.16.1 Kinomega Company Information
  93. 8.16.2 Kinomega Business Overview
  94. 8.16.3 Kinomega Omega3 (Omega-3) Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Kinomega Omega3 (Omega-3) Product Portfolio
  96. 8.16.5 Kinomega Recent Developments
  97. 8.17 KD Pharma(Marine Ingredients)
  98. 8.17.1 KD Pharma(Marine Ingredients) Company Information
  99. 8.17.2 KD Pharma(Marine Ingredients) Business Overview
  100. 8.17.3 KD Pharma(Marine Ingredients) Omega3 (Omega-3) Revenue and Gross Margin (2021-2026)
  101. 8.17.4 KD Pharma(Marine Ingredients) Omega3 (Omega-3) Product Portfolio
  102. 8.17.5 KD Pharma(Marine Ingredients) Recent Developments
  103. 8.18 KD Pharma
  104. 8.18.1 KD Pharma Company Information
  105. 8.18.2 KD Pharma Business Overview
  106. 8.18.3 KD Pharma Omega3 (Omega-3) Revenue and Gross Margin (2021-2026)
  107. 8.18.4 KD Pharma Omega3 (Omega-3) Product Portfolio
  108. 8.18.5 KD Pharma Recent Developments
  109. 8.19 Hofseth BioCare
  110. 8.19.1 Hofseth BioCare Company Information
  111. 8.19.2 Hofseth BioCare Business Overview
  112. 8.19.3 Hofseth BioCare Omega3 (Omega-3) Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Hofseth BioCare Omega3 (Omega-3) Product Portfolio
  114. 8.19.5 Hofseth BioCare Recent Developments
  115. 8.20 Golden Omega
  116. 8.20.1 Golden Omega Company Information
  117. 8.20.2 Golden Omega Business Overview
  118. 8.20.3 Golden Omega Omega3 (Omega-3) Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Golden Omega Omega3 (Omega-3) Product Portfolio
  120. 8.20.5 Golden Omega Recent Developments
  121. 8.21 GC Rieber
  122. 8.21.1 GC Rieber Company Information
  123. 8.21.2 GC Rieber Business Overview
  124. 8.21.3 GC Rieber Omega3 (Omega-3) Revenue and Gross Margin (2021-2026)
  125. 8.21.4 GC Rieber Omega3 (Omega-3) Product Portfolio
  126. 8.21.5 GC Rieber Recent Developments
  127. 8.22 EPAX
  128. 8.22.1 EPAX Company Information
  129. 8.22.2 EPAX Business Overview
  130. 8.22.3 EPAX Omega3 (Omega-3) Revenue and Gross Margin (2021-2026)
  131. 8.22.4 EPAX Omega3 (Omega-3) Product Portfolio
  132. 8.22.5 EPAX Recent Developments
  133. 8.23 Croda
  134. 8.23.1 Croda Company Information
  135. 8.23.2 Croda Business Overview
  136. 8.23.3 Croda Omega3 (Omega-3) Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Croda Omega3 (Omega-3) Product Portfolio
  138. 8.23.5 Croda Recent Developments
  139. 8.24 Bioprocess Algae
  140. 8.24.1 Bioprocess Algae Company Information
  141. 8.24.2 Bioprocess Algae Business Overview
  142. 8.24.3 Bioprocess Algae Omega3 (Omega-3) Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Bioprocess Algae Omega3 (Omega-3) Product Portfolio
  144. 8.24.5 Bioprocess Algae Recent Developments
  145. 8.25 Auqi
  146. 8.25.1 Auqi Company Information
  147. 8.25.2 Auqi Business Overview
  148. 8.25.3 Auqi Omega3 (Omega-3) Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Auqi Omega3 (Omega-3) Product Portfolio
  150. 8.25.5 Auqi Recent Developments
  151. 8.26 Anti-Cancer
  152. 8.26.1 Anti-Cancer Company Information
  153. 8.26.2 Anti-Cancer Business Overview
  154. 8.26.3 Anti-Cancer Omega3 (Omega-3) Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Anti-Cancer Omega3 (Omega-3) Product Portfolio
  156. 8.26.5 Anti-Cancer Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst